The development of genetically modified (GM) crops have revolutionized U.S. agriculture by enhancing crop productivity and sustainability. However, there is a strong global consensus on the safety of GM crops-evidenced by over 4,400 risk assessments confirming no significant difference in risk between GM and non-GM crops, yet there are substantial societal, scientific, and governmental obstacles to the future expansion and integration of GM crops. This review looks at the current state of GM crop biotechnology in the U.S., focusing on the legal frameworks that control its development, the scientific discoveries that spur innovation, and the critical challenges that need addressing to ensure continued progress. The article outlines the foundational science behind GM technologies, including gene editing, precision breeding and transgenic approaches, which have made it possible to produce crop types that are more resilient and sustainable. Furthermore, the review covers the changing regulatory environment, with special attention to the difficulties in navigating federal regulations, public perception challenges, ethical considerations, and worries about the effects on the environment and human health. Lastly, the article proposes potential pathways forward, emphasizing the necessity of regulatory change, public and policymaker education, and research funding to realize the full potential of GM crops. By addressing these challenges, U.S. agriculture can continue to benefit from biotechnological advancements while maintaining safety, sustainability, and global competitiveness in the agricultural sector.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: